UNSPSC 51285205: Trimethoprim pamoate

This classification denotes the pamoate form of a urinary anti-infective agent with the molecular formula C14H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AN164J8Y0X, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears US NIH Compound Identifier 5578. European Medicines Agency schedules Trimethoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11310MIG.

UNSPSC 51285205 Trimethoprim pamoate, a Commodity code, shows no recent state and local procurement activity directly aligned with its nominal scope. The single solicitation tagged under this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—does not involve trimethoprim pamoate, an antibiotic pharmaceutical; the mismatch suggests a tagging error rather than genuine market demand under the code. The other three recent opportunities in the dataset—Texas HHS's RFI for direct-to-manufacturer pharmacy initiatives, Tampa's medical and first aid supplies IFB for fire rescue, and MMCAP's multistate RFP for generic pharmaceuticals and OTC products—address broader pharmaceutical procurement and medical supplies but contain no specific reference to trimethoprim pamoate as a line item or deliverable.

Without recent opportunities authentically tagged to this Commodity code, the dataset does not support a characterization of issuing-body mix, geographic concentration, or representative active demand for trimethoprim pamoate specifically. State and local buyers do procure pharmaceuticals through cooperative purchasing vehicles and direct RFPs, as the MMCAP and Texas HHS records demonstrate, but this particular antibiotic has not surfaced in recent state or local solicitations captured in the source. Firms evaluating this code should assess whether their customer base includes institutional purchasers (health departments, correctional systems, public health clinics, or school districts) with direct trimethoprim pamoate requirements, as demand may exist at lower visibility than the major multistate and municipal opportunities reflected here.